Home › Funds › FAYEZ SAROFIM & CO › MRK

FAYEZ SAROFIM & CO position in MRK

MERCK & CO · Health Care

FAYEZ SAROFIM & CO reported holding 1,339,001 shares of MRK (MERCK & CO) in its Q3 2026 13F filing — a position valued at US$194.6M, representing 0.47% of its reported portfolio and ranking #46 among its reported holdings. FAYEZ SAROFIM & CO has disclosed MRK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.34M sh
Reported value held$194.57M
Portfolio Weight0.47%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How FAYEZ SAROFIM & CO's MRK position evolved

FAYEZ SAROFIM & CO first disclosed a stake in MRK in Q3 2023 at 2,463,257 shares (US$253.6M). The position peaked in Q2 2024 at 2,921,940 shares, worth US$361.7M. Across 13 filings, FAYEZ SAROFIM & CO increased the stake 2 time(s), trimmed it 10 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,339,001 shares valued at US$194.6M — a reduction of -325,908 shares quarter over quarter.. Notable position changes include a 33% increase in Q2 2024 (shares fell 8% over the following quarter), a 28% trim in Q4 2025 (shares rose 15% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.46M $253.59M New
Q4 2023 2.41M $302.72M Reduce
Q1 2024 2.20M $290.76M Reduce
Q2 2024 2.92M $361.74M Add
Q3 2024 2.90M $328.78M Reduce
Q4 2024 3.20M $318.82M Add
Q1 2025 2.92M $261.87M Reduce
Q2 2025 2.62M $207.46M Reduce
Q3 2025 2.41M $201.96M Reduce
Q4 2025 1.74M $183.14M Reduce
Q1 2026 1.70M $204.54M Reduce
Q2 2026 1.66M $213.94M Reduce
Q3 2026 1.34M $194.57M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRK and 13F data

MRK (MERCK & CO) is a Health Care company. 30 other funds we track also report a position in MRK — the largest reported positions include BlackRock Inc (US$29.17B), Vanguard Group (US$26.77B), VANGUARD CAPITAL MANAGEMENT LLC (US$23.47B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRK

All MRK fund holders →

FAQ

How long has FAYEZ SAROFIM & CO held MRK?

FAYEZ SAROFIM & CO has disclosed MRK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is FAYEZ SAROFIM & CO's current position in MRK?

As of Q3 2026, FAYEZ SAROFIM & CO holds 1.34M shares of MRK (MERCK & CO), valued at $194.57M, representing 0.47% of its reported portfolio and ranking #46.

Has FAYEZ SAROFIM & CO been buying or selling MRK?

In the latest 13F filing (Q3 2026), FAYEZ SAROFIM & CO reduced its position in MRK. The position peaked in Q2 2024 at 2.92M shares.

Which other funds hold MRK?

Other major institutional holders of MRK include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.